The team that will carry on the project consists of experienced researchers and early-career scientists. It is well balanced, as there are 6 principal research fellows, 3 research associates and 3 research assistants. The team is based on the blend of proficiency and enthusiasm necessary for the successful accomplishment of the challenging project proposed. Besides the mix of experience and youth, the complementarity of the team is based on different biomedical background of the members. The team members cooperation works in synergistic manner, as evidenced by high team efficiency, demonstrated in respectable number of successfully accomplished scientific projects (four in the past five years), published papers (> 30 in the past five years), and defended PhD theses (four in the past five years).

The team has been working on pharmacological and physiological modulation of T1D and EAE in experimental animals and in in vitro systems in several projects financed by the Ministry of Science, Republic of Serbia: 03E14: “The role of cytokines in physiological and pathological conditions”, 1664: “Cellular and molecular basis of immune disorders modulation”, 143029B: “Physiological and pharmacological modulation of immunoinflammatory and malignant diseases”, OI173013: “Molecular mechanisms of physiological and pharmacological control of inflammation and cancer”, OI173035: “Cellular and molecular mechanisms of rat recovery from experimental autoimmune encephalomyelitis”, as well as international projects: “Generation of insulin-specific T regulatory cells for the treatment of type 1 diabetes” funded by Iacocca Family Foundation (USA), “Carbon monoxide-releasing molecule CORM-A1, a novel approach for treatment of type 1 diabetes” funded by EFSD New Horizons Collaborative Research Initiative, “The role of macrophage migration inhibitory factor in beta cell apoptosis and pathogenesis of obesity-associated type 2 diabetes” funded by EFSD/AstraZeneca Young Investigator Award, “Human gut microbiota transfer for novel insights into central nervous system autoimmunity pathogenesis“, financed by Alexander von Humboldt Foundation. Work on these projects produced an effective team with know-how in all the managerial, experimental, and analytical aspects needed for the successful accomplishment of the proposed project.